About this courseSkip About this course
Internet Enduring Material Sponsored by the Stanford University School of Medicine. The course will take the learner through a case-based learning activity focusing on new medications and medication algorithms.
This course is designed for physicians and allied health professionals in cardiology, family practice, primary care, internal medicine, neurology and oncology.
Presented by the Department of Medicine, division of Endocrinology, Gerontology and Metabolism at the Stanford University School of Medicine. This CME activity provides a practical approach to lifestyle and medication management for type 2 diabetes mellitus.
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Stanford University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you would like to earn CME credit from Stanford University School of Medicine for participating in this course, please review the information here prior to beginning the activity.
What you'll learnSkip What you'll learn
- Recognize the new/most recent treatment options for type 2 diabetes.
- Evaluate patients for appropriate treatments and comorbidities.
- Evaluate patients for medication/ treatment adherence.
- Formulate progression of treatment plans for patients who haven't improved on current regimens.
- Use culturally sensitive communication tactics when discussing importance and safety of medication and treatment adherence with patients.